Literature DB >> 25600911

Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.

J Xiao1, R H Yolken.   

Abstract

The intracellular protozoan Toxoplasma gondii is an exceptionally successful food and waterborne parasite that infects approximately 1 billion people worldwide. Genotyping of T. gondii isolates from all continents revealed a complex population structure. Recent research supports the notion that T. gondii genotype may be associated with disease severity. Here, we (1) discuss molecular and serological approaches for designation of T. gondii strain type, (2) overview the literatures on the association of T. gondii strain type and the outcome of human disease and (3) explore possible mechanisms underlying these strain-specific pathology and severity of human toxoplasmosis. Although no final conclusions can be drawn, it is clear that virulent strains (e.g. strains containing type I or atypical alleles) are significantly more often associated with increased frequency and severity of human toxoplasmosis. The significance of highly virulent strains can cause severe diseases in immunocompetent patients and might implicated in brain disorders such as schizophrenia should led to reconsideration of toxoplasmosis. Further studies that combine parasite strain typing and human factor analysis (e.g. immune status and genetic background) are required for better understanding of human susceptibility or resistance to toxoplasmosis.
© 2015 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Toxoplasma gondii; human factors; outcome of human infection; strain typing; toxoplasmosis; virulence

Mesh:

Year:  2015        PMID: 25600911      PMCID: PMC4361247          DOI: 10.1111/apha.12458

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  129 in total

1.  Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.

Authors:  Tze Guan Tan; Ernest Mui; Hua Cong; William H Witola; Alexandre Montpetit; Stephen P Muench; John Sidney; Jeff Alexander; Alessandro Sette; Michael E Grigg; Ajesh Maewal; Rima McLeod
Journal:  Vaccine       Date:  2010-03-26       Impact factor: 3.641

2.  Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression.

Authors:  M B Angeloni; P M Guirelli; P S Franco; B F Barbosa; A O Gomes; A S Castro; N M Silva; O A Martins-Filho; T W P Mineo; D A O Silva; J R Mineo; E A V Ferro
Journal:  Placenta       Date:  2013-09-18       Impact factor: 3.481

3.  Characterization of ROP18 alleles in human toxoplasmosis.

Authors:  Víctor Sánchez; Alejandra de-la-Torre; Jorge Enrique Gómez-Marín
Journal:  Parasitol Int       Date:  2013-10-29       Impact factor: 2.230

Review 4.  Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis.

Authors:  D S Lindsay; J P Dubey
Journal:  Parasitology       Date:  2011-09-09       Impact factor: 3.234

5.  Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis.

Authors:  Alejandra de-la-Torre; Alexander W Pfaff; Michael E Grigg; Odile Villard; Ermanno Candolfi; Jorge E Gomez-Marin
Journal:  Cytokine       Date:  2014-04-16       Impact factor: 3.861

6.  Abnormalities of neurotransmitter and neuropeptide systems in human neuroepithelioma cells infected by three Toxoplasma strains.

Authors:  Jianchun Xiao; Ye Li; Lorraine Jones-Brando; Robert H Yolken
Journal:  J Neural Transm (Vienna)       Date:  2013-07-03       Impact factor: 3.575

Review 7.  The history of Toxoplasma gondii--the first 100 years.

Authors:  Jitender P Dubey
Journal:  J Eukaryot Microbiol       Date:  2008 Nov-Dec       Impact factor: 3.346

8.  Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.

Authors:  Alejandra de-la-Torre; Arnaud Sauer; Alexander W Pfaff; Tristan Bourcier; Julie Brunet; Claude Speeg-Schatz; Laurent Ballonzoli; Odile Villard; Daniel Ajzenberg; Natarajan Sundar; Michael E Grigg; Jorge E Gomez-Marin; Ermanno Candolfi
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

9.  Serotyping of Toxoplasma gondii in cats (Felis domesticus) reveals predominance of type II infections in Germany.

Authors:  Pavlo Maksimov; Johannes Zerweck; Jitender P Dubey; Nikola Pantchev; Caroline F Frey; Aline Maksimov; Ulf Reimer; Mike Schutkowski; Morteza Hosseininejad; Mario Ziller; Franz J Conraths; Gereon Schares
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

10.  Single nucleotide polymorphisms in the interferon gamma gene are associated with distinct types of retinochoroidal scar lesions presumably caused by Toxoplasma gondii infection.

Authors:  Ricardo Guerra Peixe; Marcela Santana Bastos Boechat; Alba Lucinia Peixoto Rangel; Rhônia França Gomes Rosa; Maria Luiza Petzl-Erler; Lilian M G Bahia-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-02       Impact factor: 2.743

View more
  39 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 2.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

3.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

4.  Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia.

Authors:  Ye Li; Emily G Severance; Raphael P Viscidi; Robert H Yolken; Jianchun Xiao
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 5.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

Review 6.  Neuroimmunology of Common Parasitic Infections in Africa.

Authors:  Richard Idro; Rodney Ogwang; Antonio Barragan; Joseph Valentino Raimondo; Willias Masocha
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

7.  1,3,4-Thiadiazoles Effectively Inhibit Proliferation of Toxoplasma gondii.

Authors:  Lidia Węglińska; Adrian Bekier; Katarzyna Dzitko; Barbara Pacholczyk-Sienicka; Łukasz Albrecht; Tomasz Plech; Piotr Paneth; Agata Paneth
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

8.  Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV).

Authors:  Jianchun Xiao; Fiona Bhondoekhan; Eric C Seaberg; Otto Yang; Valentina Stosor; Joseph B Margolick; Robert H Yolken; Raphael P Viscidi
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

9.  The Association of Toxoplasma gondii IgG and Cardiovascular Biomarkers.

Authors:  Amani Babekir; Sayed Mostafa; Emmanuel Obeng-Gyasi
Journal:  Int J Environ Res Public Health       Date:  2021-05-05       Impact factor: 3.390

10.  Toxoplasma gondii in Slaughtered Sheep in High- and Low-Humidity Regions in the South of Iran: Molecular Prevalence and Genotype Identification.

Authors:  Seyedeh Zahra Khademi; Fatemeh Ghaffarifar; Abdolhossein Dalimi; Mohammad Saaid Dayer; Amir Abdoli
Journal:  Vet Med Int       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.